BioMAdvanced Diagnostics (private company)

See something wrong or missing? Let us know
Offices:Nantes
Business model:B2B

BioMAdvanced Diagnostics is a French startup spin-off of CR2TI (Centre de Recherche Translationnelle en Transplantation et Immunologie, Université de Nantes) and Nantes University Hospital, working on the identification of biomarkers to assess, predict and diagnose the risk of transplant rejection.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 3.2M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to BioMAdvanced Diagnostics

Name Criteria
Switzerland Bionomous
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 1M - 5M USD
United Kingdom iLoF
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 1M - 5M USD
Spain Naru Intelligence
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 4
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Novai
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Poland Molecule.one
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Clustermarket
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
Spain Nanoligent
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom OxDX
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 1
  • Total raised in a similar range: 1M - 5M USD
United Kingdom Exogene
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 2
  • Total raised in a similar range: 1M - 5M USD
United Kingdom CardiaTec Biosciences
60%
  • Similar verticals: Biotech, Health services, Software Services
  • Similar business models: B2B
  • At least one other investor: found 3
  • Total raised in a similar range: 1M - 5M USD
Top